Form 4: OptimizeRx CEO Sells Shares for Tax Withholding

OptimizeRx Corp's CEO, Stephen L. Silvestro, disposed of 3,361 common shares at $12.74 each to cover tax obligations from restricted stock unit vesting.

Summary

• Stephen L. Silvestro, Chief Executive Officer of OptimizeRx Corp (OPRX), disposed of 3,361 shares of common stock.
• The transaction occurred on December 23, 2025, at a price of $12.74 per share.
• These shares were withheld by the Issuer (OptimizeRx Corp) upon the vesting of restricted stock units to satisfy Mr. Silvestro's tax withholding obligations.
• The disposition was made pursuant to a Rule 10b5-1 plan adopted on March 11, 2021.
• Following this transaction, Mr. Silvestro beneficially owns 190,507 shares of OptimizeRx Corp common stock.

Sentiment

Score: 5

Explanation: The transaction is a routine, non-discretionary disposition of shares for tax withholding purposes, which is a common occurrence for executive compensation. It does not indicate a change in management's outlook or a strategic shift.

Positives

• The disposition was for tax withholding purposes, which is a routine and expected event for executive compensation involving restricted stock units.
• The transaction was executed under a pre-arranged Rule 10b5-1 plan, indicating a structured approach to share sales and reducing concerns about opportunistic trading.

Negatives

• No inherently negative aspects as the disposition was for tax withholding, a non-discretionary event.

Risks

• No specific risks are mentioned in this Form 4 filing.

Future Outlook

The filing does not contain any forward-looking statements or guidance.

Management Comments

• No direct quotes or paraphrased statements from management are included in this Form 4 filing.

Industry Context

This Form 4 filing reports a routine insider transaction related to executive compensation. Such transactions are common across industries when restricted stock units vest, and executives are required to cover tax liabilities. It does not provide specific insights into broader industry trends or competitive landscape.

Comparison to Industry Standards

• The disposition of shares to cover tax withholding upon the vesting of restricted stock units is a standard practice for executive compensation in publicly traded companies across various industries. This type of transaction is a common mechanism for executives to manage their tax obligations related to equity awards. No specific comparable companies or projects are mentioned in the filing.

Related Party Transactions

• The transaction involves the CEO and the company for tax withholding, which is a standard compensation-related dealing. No other related party transactions are disclosed.

Stakeholder Impact

• Shareholders: Minimal direct impact as it's a routine tax-related disposition. The number of shares is small relative to the company's total outstanding shares.
• Employees, Customers, Suppliers, Creditors: No direct impact from this specific transaction.

Next Steps

• No specific future actions, events, or milestones are mentioned in this filing.

Key Dates

Keywords

OptimizeRx Corp, OPRX, Stephen L. Silvestro, CEO, Form 4, Insider transaction, Stock sale, Tax withholding, Restricted stock units, Rule 10b5-1 plan